3-溴-N-(2-羟基-1,1-二甲基乙基)苯甲酰胺 | 211388-38-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-溴-N-(2-羟基-1,1-二甲基乙基)苯甲酰胺
• 英文名称: 3-bromo-N-(2-hydroxy-1,1-dimethylethyl)benzamide
• 英文别名: 3-bromo-N-[2-(2-methyl-2-propan-1-ol)]benzamide；3-bromo-N-(1-hydroxy-2-methylpropan-2-yl)benzamide
• CAS: 211388-38-4
• 化学式: C₁₁H₁₄BrNO₂
• mdl: MFCD11929357
• 分子量: 272.142
• InChiKey: DLORAXUPPVMXLU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.363
• 拓扑面积：
  49.3
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-溴-N-(2-羟基-1,1-二甲基乙基)苯甲酰胺 在 正丁基锂 、 氯化亚砜 作用下， 以 四氢呋喃 为溶剂， 反应 0.25h， 生成 2-(3-Formylphenyl)-4,4-dimethyl-4,5-dihydrooxazole
  参考文献：
  名称：

  Fluoride ion-induced cyclization of o-[bis(trimethylsilyl)methyl]-N-acylbenzamide derivatives. New efficient synthesis of 2,3-differentially substituted 1(2H)-isoquinolones

  摘要：

  已经通过氟离子诱导的烯化反应，获得了多种2-烷基-3-烷基、3-芳基和3-杂芳基-1(2H)-异喹啉酮衍生物，这些衍生物来自于o-[双(三甲基硅基)甲基]-N-酰基苯胺衍生物。

  DOI：

  10.1039/a605077h
• 作为产物：
  描述：

  间溴苯甲酸 在 氯化亚砜 作用下， 生成 3-溴-N-(2-羟基-1,1-二甲基乙基)苯甲酰胺
  参考文献：
  名称：

  Fluoride ion-induced cyclization of o-[bis(trimethylsilyl)methyl]-N-acylbenzamide derivatives. New efficient synthesis of 2,3-differentially substituted 1(2H)-isoquinolones

  摘要：

  已经通过氟离子诱导的烯化反应，获得了多种2-烷基-3-烷基、3-芳基和3-杂芳基-1(2H)-异喹啉酮衍生物，这些衍生物来自于o-[双(三甲基硅基)甲基]-N-酰基苯胺衍生物。

  DOI：

  10.1039/a605077h

文献信息

• Synthesis and Biological Activity of New 3-Hydroxy-3-methylglutaryl-CoA Synthase Inhibitors: 2-Oxetanones with a Side Chain Mimicking the Extended Structure of 1233A.
  作者：Hirokazu HASHIZUME、Hajime ITO、Tadanori MORIKAWA、Naoaki KANAYA、Hajime NAGASHIMA、Hiroyuki USUI、Hiroshi TOMODA、Toshiaki SUNAZUKA、Hidetoshi KUMAGAI、Satoshi OMURA

  DOI：10.1248/cpb.42.2097

  日期：——

  Structural analogs of 1233A, a microbial metabolite inhibiting 3-hydroxy-3- methylglutaryl coenzyme A (HMG-CoA) synthase, were designed and synthesized. The 2-oxetanone moiety was left intact. All analogs prepared were tested for inhibition of HMG-CoA synthase activity and sterol synthesis in mouse liver and for effect on serum triglyceride levels. Of these analogs, trans-4-[2-[3-(7-carboxy-2- nap

  设计并合成了1233A（一种抑制3-羟基-3-甲基戊二酰辅酶A（HMG-CoA）合酶）的微生物代谢产物的结构类似物。保留2-氧杂环丁酮部分完整。测试了所有制备的类似物在小鼠肝脏中对HMG-CoA合酶活性和固醇合成的抑制作用，以及对血清甘油三酯水平的影响。在这些类似物中，反式-4- [2- [3-（7-羧基-2-萘基）苯基]乙基] -3-羟甲基-2-氧杂环丁酮（4a）在体外具有最高的抑制活性，并且在体外具有抑制作用。体内抑制活性，而不会引起甘油三酸酯水平的任何增加。
• Synthesis of 4-oxazolinephenylboronic acid and heterobiaryl oxazolines via a Suzuki Reaction
  作者：Samir Ghosh、A. Sanjeev Kumar、G.N. Mehta、R. Soundararajan、Subhabrata Sen

  DOI：10.3184/030823409x431355

  日期：2009.4

  An efficient synthesis of 4-oxazolinephenylboronic acid from 4-bromobenzoic acid is reported. The title compound couples with heteroaryl halides in presence of Pd(PPh₃)₄ and Na₂CO₃ in aqueous toluene to give heterobiaryl oxazolines.

  报告了从 4-溴苯甲酸高效合成 4-噁唑啉苯硼酸的方法。在 Pd(PPh3)4 和 Na2CO3 的存在下，标题化合物在甲苯水溶液中与杂芳基卤化物偶联，生成杂芳基噁唑啉。
• Rational design and synthesis of a highly effective transition state analog inhibitor of the RTEM-1 β-lactamase
  作者：Richard Martin、J. Bryan Jones

  DOI：10.1016/0040-4039(95)01799-n

  日期：1995.11

  enyl)ethane boronic acid , a rationally designed transition state analog competitive inhibitor of the RTEM-1 β-lactamase from Escherichia coli, is reported Kinetic measurements show that, as designed, it is a highly effective reversible inhibitor of the β-lactamase, with an inhibition constant of 110 nM This is the most potent competitive inhibitor of a β-lactamase yet reported.

  据报道，从大肠杆菌中合成了合理设计的RTEM-1β-内酰胺酶过渡态类似竞争抑制剂（1R）-1-乙酰氨基-2-（3-羧基苯基）乙烷硼酸。经设计，它是一种高效的β-内酰胺酶可逆抑制剂，抑制常数为110 nM。这是迄今为止报道的最有效的β-内酰胺酶竞争性抑制剂。
• Nitrogen-containing heterocyclic compounds and benzamide compounds and drugs containing the same
  申请人：——

  公开号：US20040224959A1

  公开（公告）日：2004-11-11

  Disclosed are compounds represented by formula (I) which have triglyceride biosynthesis inhibitory activity in the liver and inhibitory activity against the secretion of apolipoprotein B-containing lipoprotein from the liver and particularly have excellent inhibitory activity against the secretion of apolipoprotein B-containing lipoprotein, are free from side effect of accumulation of lipids in the liver, and are useful for the treatment and prevention of hyperlipidemia and arteriosclerotic diseases. In formula (I), R 1 and R 2 represent alkyl, alkoxy, cycloalkyl, phenyl, alkenyl, alkynyl, or a five- or six-membered saturated or unsaturated heterocyclic ring, or R 1 and R 2 , together with a nitrogen atom to which R 1 and R 2 are attached, may form a ring; R 3 and R 4 represent a hydrogen atom, alkyl, a halogen atom, hydroxyl, nitrile, alkoxycarbonyl, alkoxy, or carboxyl; or R 2 and R 3 may be attached to each other to form —(CH 2 ) m —, —N═CH—, —CH═N—, or —(C 1-6 alkyl)C═N—; A, D, E, and G each represent a carbon atom, or any one of A, D, E, and G represents a nitrogen atom with the other three each representing a carbon atom; Q represents a nitrogen atom or a carbon atom; Y represents a group represented by formula (II) wherein X represents a hydrogen atom, group —C(═O)N(R 5 )R 6 or group —C(═O)OR 7 , R 8 is absent or represents a bond, an oxygen atom, a sulfur atom, —SO 2 —, —SO—, —CH 2 —CH 2 —, or —CH═CH—, and R 9 and R 10 represent a hydrogen atom, alkyl, alkoxy, a halogen atom, or hydroxyl; and Z represents —(CH 2 ) n —, —O—(CH 2 ) i —, or —C(═O)NH—(CH 2 ) i —. 1

  本发明涉及一种由公式（I）表示的化合物，其在肝脏中具有三酰甘油生物合成抑制活性和抑制含载脂蛋白B的脂蛋白从肝脏分泌的活性，特别是对含载脂蛋白B的脂蛋白的分泌具有出色的抑制活性，且不会出现在肝脏中积累脂质的副作用，对于治疗和预防高脂血症和动脉粥样硬化疾病非常有用。在公式（I）中，R1和R2代表烷基、烷氧基、环烷基、苯基、烯基、炔基或五元或六元饱和或不饱和杂环环，或R1和R2与R1和R2附着的氮原子一起形成环; R3和R4代表氢原子、烷基、卤素原子、羟基、腈、烷氧羰基、烷氧基或羧基; 或R2和R3可以相互附着以形成-（CH2）m-、-N═CH-、-CH═N-或-（C1-6烷基）C═N-; A、D、E和G每个代表一个碳原子，或任何一个A、D、E和G代表一个氮原子，其他三个代表一个碳原子; Q代表一个氮原子或一个碳原子; Y代表由公式（II）表示的基团，其中X代表氢原子、基团-C(═O)N(R5)R6或基团-C(═O)OR7，R8不存在或代表一个键，一个氧原子，一个硫原子，-SO2-，-SO-，- - -或-CH═CH-，R9和R10代表氢原子、烷基、烷氧基、卤素原子或羟基; Z代表-（ ）n-、-O-（ ）i-或-C(═O)NH-（ ）i-。
• NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND BENAMIDE COMPOUNDS AND DRUGS CONTAINING THE SAME
  申请人：Meiji Seika Kaisha, Ltd.

  公开号：EP1180514A1

  公开（公告）日：2002-02-20

  Disclosed are compounds represented by formula (I) which have triglyceride biosynthesis inhibitory activity in the liver and inhibitory activity against the secretion of apolipoprotein B-containing lipoprotein from the liver and particularly have excellent inhibitory activity against the secretion of apolipoprotein B-containing lipoprotein, are free from side effect of accumulation of lipids in the liver, and are useful for the treatment and prevention of hyperlipidemia and arteriosclerotic diseases. In formula (I), R1 and R2 represent alkyl, alkoxy, cycloalkyl, phenyl, alkenyl, alkynyl, or a five- or six-membered saturated or unsaturated heterocyclic ring, or R1 and R2, together with a nitrogen atom to which R1 and R2 are attached, may form a ring; R3 and R4 represent a hydrogen atom, alkyl, a halogen atom, hydroxyl, nitrile, alkoxycarbonyl, alkoxy, or carboxyl; or R2 and R3 may be attached to each other to form -(CH2)m-, -N=CH-, -CH=N-, or -(C1-6 alkyl)C=N-; A, D, E, and G each represent a carbon atom, or any one of A, D, E, and G represents a nitrogen atom with the other three each representing a carbon atom; Q represents a nitrogen atom or a carbon atom; Y represents a group represented by formula (II) wherein X represents a hydrogen atom, group -C(=O)N(R5)R6 or group -C(=O)OR7, R8 is absent or represents a bond, an oxygen atom, a sulfur atom, -SO2-, -SO-, -CH2-CH2-, or - CH=CH-, and R9 and R10 represent a hydrogen atom, alkyl, alkoxy, a halogen atom, or hydroxyl; and Z represents - (CH2)n-, -O-(CH2)i-, or -C(=O)NH-(CH2)i-.

  本发明公开了式(I)代表的化合物，该化合物具有抑制肝脏中甘油三酯生物合成的活性和抑制肝脏分泌含脂蛋白B的脂蛋白的活性，特别是对肝脏分泌含脂蛋白B的脂蛋白具有极好的抑制活性，无肝脏中脂类蓄积的副作用，可用于治疗和预防高脂血症和动脉硬化性疾病。在式（I）中，R1 和 R2 代表烷基、烷氧基、环烷基、苯基、烯基、炔基或五元或六元饱和或不饱和杂环，或 R1 和 R2 与 R1 和 R2 所连接的氮原子一起可形成一个环；R3 和 R4 代表氢原子、烷基、卤素原子、羟基、腈基、烷氧羰基、烷氧基或羧基；或 R2 和 R3 可相互连接形成-(CH2)m-、-N=CH-、-CH=N-或-(C1-6 烷基)C=N-；A、D、E 和 G 各代表一个碳原子，或 A、D、E 和 G 中的任何一个代表一个氮原子，其他三个各代表一个碳原子； Q 代表一个氮原子或一个碳原子；Y 代表由式 (II) 所代表的基团，其中 X 代表氢原子、基团-C(=O)N(R5)R6 或基团-C(=O)OR7，R8 不存在或代表键、氧原子、硫原子、-SO2-、-SO-、- - - 或-CH=CH-，R9 和 R10 代表氢原子、烷基、烷氧基、卤素原子或羟基；Z 代表-( )n-、-O-( )-i 或-C(=O)NH-( )-i。